Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Neurotech International Ltd
NTICurrent price
0.069 AUD
+0.002 AUD (+2.99%)
Last closed
0.067 AUD
Company
www.neurotechinternational.com
ISIN
AU000000NTI9
Sector
Healthcare
Industry
Medical Devices
Exchange
Australian Securities Exchange
Capitalization
62 022 096 AUD
Yield for 12 month
+25.45 %
1Y
3Y
5Y
10Y
15Y
NTI
Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercialization of NTI164 for multiple paediatric neurological disorders; and Mente, a clinically proven home therapy aimed at enhancing engagement and relaxation in autistic children exhibiting elevated delta band brain activity. It also engages in executing medical research projects; and developing technological devices. The company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its proprietary NTI/Dolce cannabis strains. Neurotech International Limited was incorporated in 2016 and is based in Nedlands, Australia. Address: 145 Stirling Highway, Nedlands, WA, Australia, 6009
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.92 AUDP/E ratio
–Dividend Yield
–Current Year
+1 962 AUD
Last Year
+5 953 AUD
Current Quarter
-33 215 AUD
Last Quarter
+1 505 AUD
Current Year
-5 863 AUD
Last Year
+4 211 AUD
Current Quarter
-2 263 044 AUD
Last Quarter
-948 354 AUD
Key Figures NTI
1 year
3 years
5 years
10 years
EBITDA
-5 222 179 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-37.29 %
PEG Ratio
–
Return On Equity TTM
-63.92 %
Wall Street Target Price
0.92 AUD
Revenue TTM
3 174 513 AUD
Book Value
0.012 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
167.5 %
Dividend Yield
–
Gross Profit TTM
1 193 428 AUD
Earnings per share
-0.01 AUD
Diluted Eps TTM
-0.01 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-159.54 %
Dividend Analytics NTI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NTI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
8:7
Payout Ratio
–
Last Split Date
01.02.2019
Dividend Date
–
Stock Valuation NTI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
24910.8008
Price Sales TTM
19.5375
Enterprise Value EBITDA
-6.7445
Price Book MRQ
5.0867
Financials NTI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NTI
For 52 weeks
0.048 AUD
0.12 AUD
50 Day MA
0.057 AUD
Shares Short Prior Month
–
200 Day MA
0.076 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart